Essential control of mitochondrial morphology and function by chaperone-mediated autophagy through degradation of PARK7

Autophagy

Volumn 12, Issue 8, 2016, Pages 1215-1228

  Wang, Bao ^a   Cai, Zhibiao ^a   Tao, Kai ^a   Zeng, Weijun ^a   Lu, Fangfang ^a   Yang, Ruixin ^a   Feng, Dayun ^a   Gao, Guodong ^a   Yang, Qian ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

CMA; DJ 1; mitochondria; neuronal death; PARK7; Parkinson disease

Indexed keywords

CHAPERONE; DJ 1 PROTEIN; NEUROTOXIN; ANTIOXIDANT; PARK7 PROTEIN, HUMAN; PARK7 PROTEIN, MOUSE; PARK7 PROTEIN, RAT; PROTEIN DEGLYCASE DJ-1;

ARTICLE; CELL DEATH; CELL FUNCTION; CELL STRUCTURE; CELL SURVIVAL; CELL VIABILITY; CHAPERONE-MEDIATED AUTOPHAGY; CONTROLLED STUDY; HUMAN; HUMAN CELL; LYSOSOME MEMBRANE; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; MITOPHAGY; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOGENESIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN HOMEOSTASIS; RECESSIVE GENE; ANIMAL; AUTOPHAGY; DEGENERATIVE DISEASE; GENE EXPRESSION REGULATION; HEK293 CELL LINE; HOMEOSTASIS; LYSOSOME; MALE; METABOLISM; MOUSE; NERVE CELL; PROTEIN MOTIF; SPRAGUE DAWLEY RAT; TRANSGENIC MOUSE;

AMINO ACID MOTIFS; ANIMALS; ANTIOXIDANTS; AUTOPHAGY; CELL DEATH; CELL SURVIVAL; GENE EXPRESSION REGULATION; HEK293 CELLS; HOMEOSTASIS; HUMANS; LYSOSOMES; MALE; MICE; MICE, TRANSGENIC; MITOCHONDRIA; MOLECULAR CHAPERONES; NEURODEGENERATIVE DISEASES; NEURONS; OXIDATIVE STRESS; PARKINSON DISEASE; PROTEIN DEGLYCASE DJ-1; RATS, SPRAGUE-DAWLEY;

EID: 84974662304     PISSN: 15548627     EISSN: 15548635     Source Type: Journal    
DOI: 10.1080/15548627.2016.1179401     Document Type: Article

References (57)

1. J.M.Fearnley, A.J.Lees. Ageing and Parkinson's disease:substantia nigra regional selectivity. Brain 1991; 114:2283-301; PMID:1933245; http://dx.doi.org/10.1093/brain/114.5.2283
2. C.Henchcliffe, M.F.Beal. Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis. Nat Clin Pract Neurol 2008; 4:600-9; PMID:18978800; http://dx.doi.org/10.1038/ncpneuro0924
3. W.E.Balch, R.I.Morimoto, A.Dillin, J.W.Kelly. Adapting proteostasis for disease intervention. Science 2008; 319:916-9; PMID:18276881; http://dx.doi.org/10.1126/science.1141448
4. M.Komatsu, S.Waguri, T.Chiba, S.Murata, J.-I.Iwata, I.Tanida, T.Ueno, M.Koike, Y.Uchiyama, E.Kominami, et al. Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature 2006; 441:880-4; PMID:16625205; http://dx.doi.org/10.1038/nature04723
5. L.-Q.He, J.-H.Lu, Z.-Y.Yue. Autophagy in ageing and ageing-associated diseases. Acta Pharmacol Sin 2013; 34:605-11; PMID:23416930; http://dx.doi.org/10.1038/aps.2012.188
6. B.Dehay, M.Martinez‐Vicente, G.A.Caldwell, K.A.Caldwell, Z.Yue, M.R.Cookson, C.Klein, M.Vila, E.Bezard. Lysosomal impairment in Parkinson's disease. Movement Disord 2013; 28:725-32; PMID:23580333; http://dx.doi.org/10.1002/mds.25462
7. J.Trinh, M.Farrer. Advances in the genetics of Parkinson disease. Nat Rev Neurol 2013; 9:445-54; PMID:23857047; http://dx.doi.org/10.1038/nrneurol.2013.132
8. J.F.Dice. Chaperone-mediated autophagy. Autophagy 2007; 3:295-9; PMID:17404494; http://dx.doi.org/10.4161/auto.4144
9. D.C.Velseboer, R.J.de Haan, W.Wieling, D.S.Goldstein, R.M.de Bie. Prevalence of orthostatic hypotension in Parkinson's disease:a systematic review and meta-analysis. Parkinsonism Relat Disord 2011; 17:724-9; PMID:21571570; http://dx.doi.org/10.1016/j.parkreldis.2011.04.016
10. A.M.Cuervo, L.Stefanis, R.Fredenburg, P.T.Lansbury, D.Sulzer. Impaired degradation of mutant α-synuclein by chaperone-mediated autophagy. Science 2004; 305:1292-5; PMID:15333840; http://dx.doi.org/10.1126/science.1101738
11. S.J.Orenstein, S.-H.Kuo, I.Tasset, E.Arias, H.Koga, I.Fernandez-Carasa, E.Cortes, L.S.Honig, W.Dauer, A.Consiglio, et al. Interplay of LRRK2 with chaperone-mediated autophagy. Nat Neurosci 2013; 16:394-406; PMID:23455607; http://dx.doi.org/10.1038/nn.3350
12. T.Kabuta, A.Furuta, S.Aoki, K.Furuta, K.Wada. Aberrant interaction between Parkinson disease-associated mutant UCH-L1 and the lysosomal receptor for chaperone-mediated autophagy. J Biol Chem 2008; 283:23731-8; PMID:18550537; http://dx.doi.org/10.1074/jbc.M801918200
13. T.Kabuta, K.Wada. Insights into links between familial and sporadic Parkinson's disease:physical relationship between UCH-L1 variants and chaperone-mediated autophagy. Autophagy 2008; 4:827-9; PMID:18635949; http://dx.doi.org/10.4161/auto.6560
14. Q.Yang, H.She, M.Gearing, E.Colla, M.Lee, J.J.Shacka, Z.Mao. Regulation of neuronal survival factor MEF2D by chaperone-mediated autophagy. Science 2009; 323:124-7; PMID:19119233; http://dx.doi.org/10.1126/science.1166088
15. L.Gao, H.She, W.Li, J.Zeng, J.Zhu, D.P.Jones, Z.Mao, G.Gao, Q.Yang. Oxidation of survival factor MEF2D in neuronal death and Parkinson's disease. Antioxid Redox Signal 2014; 20:2936-48; PMID:24219011; http://dx.doi.org/10.1089/ars.2013.5399
16. B.Wang, Z.Cai, F.Lu, C.Li, X.Zhu, L.Su, G.Gao, Q.Yang. Destabilization of survival factor MEF2D mRNA by neurotoxin in models of Parkinson's disease. J Neurochem 2014; 130:720-8; PMID:24848448; http://dx.doi.org/10.1111/jnc.12765
17. L.Alvarez-Erviti, M.C.Rodriguez-Oroz, J.M.Cooper, C.Caballero, I.Ferrer, J.A.Obeso, A.H.Schapira. Chaperone-mediated autophagy markers in Parkinson disease brains. Arch Neurol-chicago 2010; 67:1464-72; PMID:20697033; http://dx.doi.org/10.1001/archneurol.2010.198
18. M.A.Wilson, J.L.Collins, Y.Hod, D.Ringe, G.A.Petsko. The 1.1-Å resolution crystal structure of DJ-1, the protein mutated in autosomal recessive early onset Parkinson's disease. Proc Natl Acad Sci U S A 2003; 100:9256-61; PMID:12855764; http://dx.doi.org/10.1073/pnas.1133288100
19. P.J.Kahle, J.Waak, T.Gasser. DJ-1 and prevention of oxidative stress in Parkinson's disease and other age-related disorders. Free Radical Bio Med 2009; 47:1354-61; PMID:19686841; http://dx.doi.org/10.1016/j.freeradbiomed.2009.08.003
20. M.K.McCoy, M.R.Cookson. DJ-1 regulation of mitochondrial function and autophagy through oxidative stress. Autophagy 2011; 7:531-2; PMID:21317550
21. L.Miller-Fleming, P.Antas, T.F.Pais, J.L.Smalley, F.Giorgini, T.F.Outeiro. Yeast DJ-1 superfamily members are required for diauxic-shift reprogramming and cell survival in stationary phase. Proc Natl Acad Sci U S A 2014; 111:7012-7; PMID:24706893; http://dx.doi.org/10.1073/pnas.1319221111
22. D.W.Miller, R.Ahmad, S.Hague, M.J.Baptista, R.Canet-Aviles, C.McLendon, D.M.Carter, P.P.Zhu, J.Stadler, J.Chandran, et al. L166P mutant DJ-1, causative for recessive Parkinson's disease, is degraded through the ubiquitin-proteasome system. J Biol Chem 2003; 278:36588-95; PMID:12851414; http://dx.doi.org/10.1074/jbc.M304272200
23. V.Bonifati, P.Rizzu, M.J.van Baren, O.Schaap, G.J.Breedveld, E.Krieger, M.C.Dekker, F.Squitieri, P.Ibanez, M.Joosse, et al. Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 2003; 299:256-9; PMID:12446870; http://dx.doi.org/10.1126/science.1077209
24. J.Choi, M.C.Sullards, J.A.Olzmann, H.D.Rees, S.T.Weintraub, D.E.Bostwick, M.Gearing, A.I.Levey, L.S.Chin, L.Li. Oxidative damage of DJ-1 is linked to sporadic Parkinson and Alzheimer diseases. J Biol Chem 2006; 281:10816-24; PMID:16517609; http://dx.doi.org/10.1074/jbc.M509079200
25. I.Irrcher, H.Aleyasin, E.L.Seifert, S.J.Hewitt, S.Chhabra, M.Phillips, A.K.Lutz, M.W.Rousseaux, L.Bevilacqua, A.Jahani-Asl, et al. Loss of the Parkinson's disease-linked gene DJ-1 perturbs mitochondrial dynamics. Hum Mol Genet 2010; 19:3734-46; PMID:20639397; http://dx.doi.org/10.1093/hmg/ddq288
26. D.J.Moore, L.Zhang, J.Troncoso, M.K.Lee, N.Hattori, Y.Mizuno, T.M.Dawson, V.L.Dawson. Association of DJ-1 and parkin mediated by pathogenic DJ-1 mutations and oxidative stress. Hum Mol Genet 2005; 14:71-84; PMID:15525661; http://dx.doi.org/10.1093/hmg/ddi007
27. J.H.Son, H.S.Chun, T.H.Joh, S.Cho, B.Conti, J.W.Lee. Neuroprotection and neuronal differentiation studies using substantia nigra dopaminergic cells derived from transgenic mouse embryos. J Neurosci 1999; 19:10-20; PMID:9870933
28. G.Fuertes, J.Martindellano, A.Villarroya, A.Rivett, E.Knecht. Changes in the proteolytic activities of proteasomes and lysosomes in human fibroblasts produced by serum withdrawal, amino-acid deprivation and confluent conditions. Biochem j 2003; 375:75-86; PMID:12841850; http://dx.doi.org/10.1042/bj20030282
29. A.E.Majeski, J.F.Dice. Mechanisms of chaperone-mediated autophagy. Int J Biochem Cell Biol 2004; 36:2435-44; PMID:15325583; http://dx.doi.org/10.1016/j.biocel.2004.02.013
30. U.Bandyopadhyay, A.M.Cuervo. Entering the lysosome through a transient gate by chaperone-mediated autophagy. Autophagy 2008; 4:1101-3; PMID:18927485; http://dx.doi.org/10.4161/auto.7150
31. A.M.Cuervo, J.F.Dice. A receptor for the selective uptake and degradation of proteins by lysosomes. Science 1996; 273:501-3; PMID:8662539; http://dx.doi.org/10.1126/science.273.5274.501
32. M.C.Meulener, K.Xu, L.Thomson, H.Ischiropoulos, N.M.Bonini. Mutational analysis of DJ-1 in Drosophila implicates functional inactivation by oxidative damage and aging. Proc Natl Acad Sci U S A 2006; 103:12517-22; PMID:16894167; http://dx.doi.org/10.1073/pnas.0601891103
33. G.Robert, A.Puissant, M.Dufies, S.Marchetti, A.Jacquel, T.Cluzeau, P.Colosetti, N.Belhacene, P.Kahle, C.A.Da Costa, et al. The caspase 6 derived N-terminal fragment of DJ-1 promotes apoptosis via increased ROS production. Cell Death Differ 2012; 19:1769-78; PMID:22555455; http://dx.doi.org/10.1038/cdd.2012.55
34. J.D.Hulleman, H.Mirzaei, E.Guigard, K.L.Taylor, S.S.Ray, C.M.Kay, F.E.Regnier, J.C.Rochet. Destabilization of DJ-1 by familial substitution and oxidative modifications:implications for Parkinson's disease. Biochemistry-us 2007; 46:5776-89; PMID:17451229; http://dx.doi.org/10.1021/bi7001778
35. I.Irrcher, H.Aleyasin, E.Seifert, S.Hewitt, S.Chhabra, M.Phillips, A.K.Lutz, M.W.Rousseaux, L.Bevilacqua, A.Jahani-Asl, et al. Loss of the Parkinson's disease-linked gene DJ-1 perturbs mitochondrial dynamics. Hum Mol Genet 2010; 19:3734-46; PMID:20639397; http://dx.doi.org/10.1093/hmg/ddq288
36. H.Chen, D.C.Chan. Mitochondrial dynamics–fusion, fission, movement, and mitophagy–in neurodegenerative diseases. Hum Mol Genet 2009; 18:R169-R76; PMID:19808793; http://dx.doi.org/10.1093/hmg/ddp326
37. J.H.Zhu, A.M.Gusdon, H.Cimen, B.Van Houten, E.Koc, C.T.Chu. Impaired mitochondrial biogenesis contributes to depletion of functional mitochondria in chronic MPP+ toxicity:dual roles for ERK1/2. Cell Death Dis 2012; 3:e312; PMID:22622131; http://dx.doi.org/10.1038/cddis.2012.46
38. R.Kiffin, C.Christian, E.Knecht, A.M.Cuervo. Activation of chaperone-mediated autophagy during oxidative stress. Mol Biol Cell 2004; 15:4829-40; PMID:15331765; http://dx.doi.org/10.1091/mbc.E04-06-0477
39. A.M.Cuervo, E.Wong. Chaperone-mediated autophagy:roles in disease and aging. Cell Res 2014; 24:92-104; PMID:24281265; http://dx.doi.org/10.1038/cr.2013.153
40. M.Rubio-Osornio, E.Gorostieta-Salas, S.Montes, F.Pérez-Severiano, C.Rubio, C.Gómez, C.Ríos, J.Guevara. Epicatechin Reduces Striatal MPP+-Induced Damage in Rats through Slight Increases in SOD-Cu, Zn Activity. Oxid Med Cell Longev 2015; 2015; PMID:26301040; http://dx.doi.org/10.1155/2015/276039
41. S.S.Titze-de-Almeida, C.F.Lustosa, C.H.Horst, E.Del Bel, R.Titze-de-Almeida. Interferon Gamma Potentiates the Injury Caused by MPP (+) on SH-SY5Y Cells, Which is Attenuated by the Nitric Oxide Synthases Inhibition. Neurochem Res 2014; 39:2452-64; PMID:25297574; http://dx.doi.org/10.1007/s11064-014-1449-1
42. Y.-H.Tsou, C.-T.Shih, C.-H.Ching, J.-Y.Huang, C.J.Jen, L.Yu, Y.M.Kuo, F.S.Wu, J.I.Chuang. Treadmill exercise activates Nrf2 antioxidant system to protect the nigrostriatal dopaminergic neurons from MPP+ toxicity. Exp Neurol 2015; 263:50-62; PMID:25286336; http://dx.doi.org/10.1016/j.expneurol.2014.09.021
43. C.-M.Chong, M.Shen, Z.-Y.Zhou, P.Pan, P.-M.Hoi, S.Li, W.Liang, N.Ai, L.Q.Zhang, C.W.Li, et al. Discovery of a benzofuran derivative (MBPTA) as a novel ROCK inhibitor that protects against MPP+-induced oxidative stress and cell death in SH-SY5Y cells. Free Radical Bio Med 2014; 74:283-93; PMID:24973649; http://dx.doi.org/10.1016/j.freeradbiomed.2014.06.014
44. W.Li, Q.Yang, Z.Mao. Chaperone-mediated autophagy:machinery, regulation and biological consequences. Cell Mol Life Sci 2011; 68:749-63; PMID:20976518; http://dx.doi.org/10.1007/s00018-010-0565-6
45. X.Liu, S.Huang, X.Wang, B.Tang, W.Li, Z.Mao. Chaperone-mediated autophagy and neurodegeneration:connections, mechanisms, and therapeutic implications. Neurosci Bull 2015; 31:407-15; PMID:26206600; http://dx.doi.org/10.1007/s12264-015-1542-8
46. Z.Cai, W.Zeng, K.Tao, E.Zhen, B.Wang, Q.Yang. Chaperone-mediated autophagy:roles in neuroprotection. Neurosci Bull 2015; 31:452-8; PMID:26206599; http://dx.doi.org/10.1007/s12264-015-1540-x
47. X.Gong, X.Tang, M.Wiedmann, X.Wang, J.Peng, D.Zheng, L.A.Blair, J.Marshall, Z.Mao. Cdk5-mediated inhibition of the protective effects of transcription factor MEF2 in neurotoxicity-induced apoptosis. Neuron 2003; 38:33-46; PMID:12691662; http://dx.doi.org/10.1016/S0896-6273(03)00191-0
48. X.Tang, X.Wang, X.Gong, M.Tong, D.Park, Z.Xia, Z.Mao. Cyclin-dependent kinase 5 mediates neurotoxin-induced degradation of the transcription factor myocyte enhancer factor 2. J Neurosci 2005; 25:4823-34; PMID:15888658; http://dx.doi.org/10.1523/JNEUROSCI.1331-05.2005
49. H.She, Q.Yang, K.Shepherd, Y.Smith, G.Miller, C.Testa, Z.Mao. Direct regulation of complex I by mitochondrial MEF2D is disrupted in a mouse model of Parkinson disease and in human patients. J Clin Invest 2011; 121:930; PMID:21393861; http://dx.doi.org/10.1172/JCI43871
50. M.K.McCoy, T.N.Martinez, K.A.Ruhn, D.E.Szymkowski, C.G.Smith, B.R.Botterman, K.E.Tansey, M.G.Tansey. Blocking soluble tumor necrosis factor signaling with dominant-negative tumor necrosis factor inhibitor attenuates loss of dopaminergic neurons in models of Parkinson's disease. J Neurosci 2006; 26:9365-75; PMID:16971520; http://dx.doi.org/10.1523/JNEUROSCI.1504-06.2006
51. S.Sahay, D.Ghosh, P.K.Singh, S.K.Maji. Alteration of structure and aggregation of a-synuclein by familial parkinson's disease associated mutations. Curr Protein Pept Sci 2016; PMID:26972727
52. J.R.Bae, B.D.Lee. Function and dysfunction of leucine-rich repeat kinase 2 (LRRK2):Parkinson's disease and beyond. BMB Rep 2015; 48:243-8; PMID:25703537; http://dx.doi.org/10.5483/BMBRep.2015.48.5.032
53. T.Kabuta, K.Wada. Insights into links between familial and sporadic Parkinson's disease:physical relationship between UCH-L1 variants and chaperone-mediated autophagy. Autophagy 2008; 4:827-9; PMID:18635949; http://dx.doi.org/10.4161/auto.6560
54. S.-H.Kuo, S.Orenstein, H.Koga, G.Tang, E.Kanter, R.Alcalay, et al. LRRK2 G2019S impairs chaperone-mediated autophagy in neurons (S13. 003). Neurology 2013; 80:S13. 003; http://www.neurology.org/content/80/7_Supplement/IN2-1.001.abstract
55. J.H.Son, H.S.Chun, T.H.Joh, S.Cho, B.Conti, J.W.Lee. Neuroprotection and neuronal differentiation studies using substantia nigra dopaminergic cells derived from transgenic mouse embryos. J Neurosci 1999; 19:10-20; PMID:9870933
56. A.M.Cuervo, L.Stefanis, R.Fredenburg, P.T.Lansbury, D.Sulzer. Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy. Science (New York, NY) 2004; 305:1292-5; PMID:15333840; http://dx.doi.org/10.1126/science.1101738
57. K.Trudeau, A.J.Molina, W.Guo, S.Roy. High glucose disrupts mitochondrial morphology in retinal endothelial cells:implications for diabetic retinopathy. Am J Pathol 2010; 177:447-55; PMID:20522647; http://dx.doi.org/10.2353/ajpath.2010.091029